Delivery Order SPE2DB22D6029-SPE2DB25F1474

Award Date 11/6/24
Potential Completion Date 11/7/24
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Taltz 80 mg/mL autoinjectors. The contract, valued at $36,864.94, is a firm fixed-price delivery order with an ultimate completion date of October 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is for the delivery of Taltz 80 mg/mL autoinjectors to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, in the amount of $12,564.72. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $19,605.32 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Taltz 80 mg/mL autoinjectors. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 and awarded solely to AmerisourceBergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
This federal contract award is for a Delivery Order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Taltz 80 mg/mL autoinjectors. The $21,146.42 Firm Fixed Price contract has an ultimate completion date of July 30, 2024 and was awarded on July 29, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,649.13, is for the delivery of Taltz 80 mg/mL autoinjector medication. It is a firm fixed-price delivery order contract with an ultimate completion date of April 8, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Taltz 80 mg/ml autoinjectors to the Defense Logistics Agency (DLA) Troop Support Medical, a major agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the federal government, in the amount of $29,842.15. This is a firm fixed-price delivery order contract with an ultimate completion date of August 23, 2024. The contract does not...
This federal contract award is for a delivery order worth $4,332.98 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Taltz 80 mg/ml autoinjector medication, with a completion date of December 5, 2024. The contract is a firm-fixed-price delivery order placed by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract does not have a set-aside designation,...
This federal contract award, valued at $49,717.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Taltz 80 mg/ml auto-injectors, a specialty medication used to treat certain medical conditions. The contract has an ultimate completion date of July 16, 2024 and is a firm fixed-price arrangement. AmerisourceBergen, a for-profit organization, holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Taltz 80 mg/ml autoinjectors, a medication used to treat certain medical conditions. The contract has a firm fixed price of $7,512.08 and a period of performance through May 29, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Taltz 80 mg/mL autoinjector medication. The contract has a potential value of $4,188.24 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25F1474
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Taltz 80 mg/mL autoinjector medication. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $19,771.92 and has an ultimate completion date of November 7, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current delivery order is issued under this larger IDC contract to facilitate the procurement of this specific medication. The contract does not have a set-aside designation, indicating open competition.

Generated 2/5/25, 9:12 AM